Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients-Reference-Cited by-同舟云学术

Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients

Published:2022-02-01 Issue:2 Volume:182 Page:165
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Reindl-Schwaighofer Roman¹,Heinzel Andreas¹,Mayrdorfer Manuel¹,Jabbour Rhea¹,Hofbauer Thomas M.²,Merrelaar Anne³,Eder Michael¹,Regele Florina¹,Doberer Konstantin¹,Spechtl Paul¹,Aschauer Constantin¹,Koblischke Maximilian⁴,Paschen Christopher¹,Eskandary Farsad¹,Hu Karin¹,Öhler Barbara¹,Bhandal Arshdeep¹,Kleibenböck Sabine¹,Jagoditsch Rahel I.¹,Reiskopf Bianca¹,Heger Florian⁵,Bond Gregor¹,Böhmig Georg A.¹,Strassl Robert⁶,Weseslindtner Lukas⁴,Indra Alexander⁵⁷,Aberle Judith H.⁴,Binder Michael⁸,Oberbauer Rainer¹

Affiliation:

1. Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

2. Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria

3. Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria

4. Center for Virology, Medical University of Vienna, Vienna, Austria

5. Institute for Medical Microbiology and Hygiene, Austrian Agency for Health and Food Safety, Vienna, Austria

6. Division of Virology, Department of Laboratory Medicine, Medical University Vienna, Vienna, Austria

7. Paracelsus Medical University of Salzburg, Salzburg, Austria

8. Wiener Gesundheitsverbund, Vienna, Austria

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2787200/jamainternal_reindlschwaighofer_2021_oi_210076_1643648293.78029.pdf

Reference31 articles.

1. Initial effects of COVID-19 on patients with ESKD.;Weinhandl;J Am Soc Nephrol,2021

2. An early experience on the effect of solid organ transplant status on hospitalized COVID-19 patients.;Nair;Am J Transplant,2021

3. Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients.;Cowan;Transplantation,2014

4. Safety and efficacy of single-dose Ad26.CoV2.S vaccine against COVID-19.;Sadoff;N Engl J Med,2021

5. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.;Grupper;Am J Transplant,2021

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients;Viruses;2024-01-12

2. Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-CoV-2 infection in solid organ transplant recipients;Transplantation Reviews;2023-12

3. The new frontier: Clinical consequences of long COVID;Journal of Precision Respiratory Medicine;2023-12-01

4. Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients;eBioMedicine;2023-11

5. Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum;Nefrología (English Edition);2023-11